MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Positioned as Observers Expect Copper to Become the ‘New Precious/Industrial Metal’

 McEwen Mining (NYSE: MUX) (TSX: MUX) owns 51.9% of McEwen Copper, a base metal developer that is looking to solve the copper supply bottleneck by advancing its 100%-owned Los Azules Project in the San Juan province of Argentina. The project hosts a copper-gold-silver deposit whose ultimate depth and lateral extent are yet to be fully determined. “A more recent Preliminary Economic Assessment (‘PEA’) completed in 2017 highlights the project’s robust economics. The project’s average annual production throughout the first 13 years of operation is expected to be about 415 million pounds of copper at a cash cost of $1.14 per pound, placing it within the lowest cost quartile,” a recent article reads. “Tellingly, the cost is much lower than the prevailing market price of copper, further boosting the project’s economic prospects. And with the supply bottlenecks and increased demand expected to influence a continuous uptrend, the outlook appears positive. In fact, according to the article in Investing News, as the need for copper continues to grow, observers believe the red metal will become ‘the new precious/industrial metal – and it’s going to have an importance that’s equivalent to some of the more attractive metals, such as gold and silver.’”

To view the full article, visit https://ibn.fm/KbCwy

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, it has large exposure to copper through its 52% ownership of McEwen Copper, which owns the advanced stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and extend the life of its mines with the objective of increasing its share value and price and providing a yield. Rob McEwen, chairman and chief owner, has personal investment in the company of US$220 million. His annual salary is US$1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at http://ibn.fm/MUX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Expands Proprietary Chipset for Automotive Lidar with Release of Komodo

 Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced the release of Komodo, its proprietary lidar point cloud processor ASIC (Application-Specific Integrated Circuit) chip. A highly integrated custom SoC, developed by Cepton in California, Komodo is designed to maximize the technical advantages of Cepton’s patented lidar architecture to significantly improve point cloud quality while replacing several merchant silicon devices to dramatically reduce cost. Supported by the company’s deep experience in industrializing automotive lidar for volume production through its flagship ADAS lidar series production program, Komodo successfully achieved production-ready status and is expected to begin shipping in the second quarter of 2023. “Our goal is to ultimately offer our customers a customizable black-box solution with built-in perception capabilities,” said Dr. Jun Pei, CEO and co-founder of Cepton. “Since 2019, we’ve had a vision of developing a comprehensive chipset through a series of ASICs covering front-end signal processing, back-end point cloud processing and eventually perception capabilities all within the lidar unit. We started with our own signal processor ASIC, Iguana, and now we are proud to unveil Komodo.”

To view the full press release, visit https://ibn.fm/nxFxC

About Cepton Inc.

Cepton is a Silicon Valley innovator of lidar-based solutions for automotive (“ADAS/AV”), smart cities, smart spaces and smart industrial applications. With its patented lidar technology, Cepton aims to take lidar mainstream and achieve a balanced approach to performance, cost and reliability, while enabling scalable and intelligent 3D perception solutions across industries. Cepton has been awarded a significant ADAS lidar series production award with Koito on the General Motors business. Cepton is engaged with all top 10 global OEMs. Founded in 2016 and led by industry veterans with decades of collective experience across a wide range of advanced lidar and imaging technologies, Cepton is focused on the mass market commercialization of high-performance, high-quality lidar solutions. Cepton is headquartered in San Jose, California, and has a center of excellence facility in Troy, Michigan, to provide local support to automotive customers in the Metro Detroit area. Cepton also has a presence in Germany, Canada, Japan, India and China to serve a fast-growing global customer base. For more information, visit the company’s website at www.Cepton.com.

NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in Equity Research Report

 BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, was featured in an equity research report published by Aegis Capital Corp. In the report, Aegis Capital maintained a buy rating for BVXV at a $70 target price. The publication reads, “R&D expenses for 2022 of $5.8 million were in-line with our expectations and G&A expenses were a bit higher than estimated at $5.3 million. We believe R&D expenses could rise to $7 million in 2023 as the company licenses additional NanoAb candidates and assuming that a Phase 1/2a clinical trial for the anti-COVID-19 NanoAb begins this year. We expect G&A expenses to remain stable.”

To request access to the full report, visit https://ibn.fm/mD1Dv

About BiondVax Pharmaceuticals Ltd.

BiondVax is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Since its inception, BiondVax has executed eight clinical trials including a seven-country, 12,400-participant phase 3 trial of its prior vaccine candidate and has built a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (“NanoAb”) pipeline. For more information, visit the company’s website at www.BiondVax.com.

NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN), EVT Collaborate to Enhance EV Performance, Scale to Other Energy Applications

 Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a partnership with Global EV Technology, Inc. and EV Technologies, LLC. (collectively “EVT”) to form Mullen Advanced Energy Operations, LLC. (“MAEO”) with initial development for improving energy management technology in electric vehicles for greater range and vehicle performance and scaling to other energy applications. Mullen owns 51% of the newly formed entity and will consolidate the results of its operations in Mullen Automotive. Under the agreement, Global EV Technology will contribute its technology and existing contracts to MAEO, and Mullen will provide capital, execution and commercialization to grow the business. Both companies will be contributing and collaborating on known verified technology for improving existing vehicle performance and extending battery range. As this technology has immediate and key implications for electric vehicles, MAEO’s initial development will focus on improving Mullen’s lineup of commercial and consumer EVs. Lawrence Hardge, a successful life-long inventor with a storied career of over 30 years, is the founder and chief scientific officer of Global EV Technology. “Lawrence is a talented inventor, and we are excited to begin working with him on improving electric vehicle performance,” said David Michery, CEO and chairman of Mullen Automotive. “We are always looking for forward-thinking and ground-breaking technology opportunities and are pleased to partner with Global and EV Technologies.”

To view the full news release, visit https://ibn.fm/xw33w

About Mullen Automotive Inc.

Mullen is a Southern California-based automotive company building the next generation of electric vehicles (“EVs”) that will be manufactured in two company owned United States-based assembly plants. Mullen’s EV development portfolio includes the Mullen FIVE EV Crossover, Mullen Commercial Class 1-3 EVs and Bollinger Motors, which features both the B1 and B2 electric SUV trucks and Class 4-6 commercial offerings. The Mullen FIVE, the company’s first electric crossover, is slated for delivery in 2024 and features an award-winning design and its patented PERSONA technology that utilizes facial recognition to personalize the driving experience for every individual. On Sept. 7, 2022, Bollinger Motors became a majority-owned EV truck company of Mullen Automotive, and on Dec. 1, 2022, Mullen closed on the acquisition of all of Electric Last Mile Solutions’ (“ELMS”) assets, including all IP and a 650,000-square-foot plant in Mishawaka, Indiana. To learn more about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Releases Financial Report for Q4, FY 2022

 RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, is reporting record full-year revenues in its just-released financial report, which covers the fourth quarter and full year for the period ending Dec. 31, 2022. Highlights of the report included 33% growth in full-year revenue, which totaled $32.9 million on processing volume of $3.6 billion, an 83% increase from $1.95 billion processed in 2021; record Q4 revenue of $11.1 million, a 56% increase over Q4 2021; and FX and international payments business reporting more than $1 billion in business volume during 2022. In addition, corporate highlights for the company included the launch of its coyni v2 platform; expanded services in American Samoa to 256 merchants, representing more than one-half of the overall merchant market; and the signing of six global financial institutions for its Banking-as-a-Service (“BAAS”) solution, which is projected to process more than $100 million monthly month when fully ramped up. “We are proud of the meaningful strides we accomplished during 2022 towards achieving our long-term objective of becoming a disruptive force in the digital payments market,” said RYVYL CEO Fredi Nisan in the press release. “Our fiscal year 2022 was highlighted by continued top line growth leading to record revenue of $32.9 million on record annual processing volume of $3.6 billion.

The levers that drove our growth in 2022 were our merchant acquiring business and geographic expansion following the completion of our acquisition of Transact Europe, with our international transaction volume exceeding $1 billion during the year. . . . With a growing pipeline in our domestic and international acquiring businesses, market share capture in American Samoa, recent breakthrough sign ups with our banking-as-a-service solution, and plans to spin-off coyni to unlock its potential, we are well positioned for strong growth and expansion of our presence in the digital payments landscape. In 2023, we expect to see our transaction volume increase to $6 billion resulting in revenue of $60 million and a positive adjusted EBITDA of $4 million.”

To view the full press release, visit https://ibn.fm/cmGOf

About RYVYL

RYVYL was born from a passion for empowering a new way to conduct business-to-business, consumer-to-business and peer-to-peer payment transactions around the globe. By leveraging unique blockchain security and USD-pegged stablecoin technology with near real-time attestation, RYVYL is reinventing the future of financial transactions using its coyni(R) stablecoin platform as a transactional foundation. Since its founding as GreenBox POS in 2017, RYVYL has developed applications enabling an end-to-end suite of turnkey financial products with enhanced security and data privacy, world-class identity theft protection and rapid speed to settlement. As a result, the platform can log immense volumes of immutable transactional records at the speed of the internet for first-tier partners, merchants and consumers around the globe. For more information about the company, please visit www.GreenBoxPOS.com.

NOTE TO INVESTORS: The latest news and updates relating to RVYL are available in the company’s newsroom at https://ibn.fm/RVYL

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Reports FY 2022 Financial Statements, Corporate Update

 BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, published its full-year financial results for the year ended December 31, 2022; the report also included key business updates. Highlights of the report include the signing of definitive agreements with the Max Planck Society (“MPG”) and the University Medical Center Göttingen, Germany (“UMG”) designed to enable BiondVax to build a pipeline of “bio-better” nanosized VHH antibodies (NanoAbs); notice that the unique physicochemical characteristics of NanoAbs being generated by BiondVax’s scientific partners show several competitive attributes, including greater binding affinity, neutralization at lower drug concentrations, stability at high temperatures, and convenient routes of administration and formulation advantages; and an option for an exclusive worldwide license agreement at pre-agreed financial terms for additional NanoAbs discovered and characterized under the BiondVax-MPG-UMG agreement.

In addition, the company is looking at starting a phase 1/2a clinical trial while continuing to monitor the ongoing evolution of the COVID-19 virus and variants of concern (“VoCs”). “BiondVax’s recent achievements leave me very optimistic about BiondVax’s growth potential and ability to deliver value to our stakeholders,” said BiondVax CEO Amir Reichman in the press release. “This past winter we published exciting data from the proof-of-concept in vivo trial of an inhaled NanoAb therapy. Looking forward, I’m excited to exercise our option to obtain an exclusive license at pre-agreed financial terms to anti-IL-17 NanoAbs targeting safe, effective and convenient treatment of psoriatic lesions; scale up in-house NanoAb manufacturing; and conduct an in vitro proof-of-concept study and potentially also a preclinical trial of the IL-17 NanoAb as a therapy for psoriasis. The BiondVax team, in collaboration with our scientific partners from MPI-NAT and UMG, has worked exceedingly hard to develop best in class capabilities in NanoAb technology-based drug development.”

To view the full press release, visit https://ibn.fm/blcPk

About BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Since its inception, the company has executed eight clinical trials including a seven-country, 12,400-participant, phase 3 trial of its prior vaccine candidate; the company has also built a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (“NanoAb”) pipeline. For more information about the company, please visit www.BiondVax.com

NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Cepton, Inc. (NASDAQ: CPTN) Continues to Forge Innovative Partnerships to Expand Lidar Applications Across Sectors and Geographies

 

• As a lidar developer engaged with all Top 10 global automotive OEMs, Cepton is established in the automotive space; but as a technology that allows examination of natural and manmade environments with accuracy and precision, lidar can offer much more
• In addition to its work with leading automotive OEMs, Cepton has been also committed to forging partnerships beyond the automotive sector to improve infrastructure efficiency and safety around the world
• Cepton’s low-cost, high-resolution perception devices that enable scanning of environments have been deployed in projects around the world to transform spaces into smart infrastructure

Often coined as one of the most useful and versatile technologies of our time, lidar use cases go beyond merely enabling driver assistance functions in vehicles – although this is the application the technology is widely known for. As an optical technology that uses infrared light to measure distances, localize objects, or create maps of various areas with accuracy and precision, it can be used in practically any industry, from autonomous driving and logistics to robotics, construction, security, and agriculture, enhancing safety and productivity across a variety of end markets. As a provider of smart 3D-sensing lidar solutions, Cepton (NASDAQ: CPTN) has been collaborating with a number of global partners over the years to bring unique and accurate 3D imaging capabilities of this powerful technology beyond automotive applications to transform spaces into intelligent infrastructure.

Some of the collaborative projects include high-fidelity mapping and smart analytics on the fly for applications such as 3D modeling for building information modeling, historical site mapping, terrain modeling, volumetric mining calculations, power line inspection and forestry mapping (https://ibn.fm/EySVz). Another notable partnership includes security applications in surveillance and facility management, a project where Cepton’s smart lidar was deployed seamlessly with the client’s other sensors to provide a complete image of the monitored space, enabling high-resolution visual capture of the environment and activities within it (https://ibn.fm/tv0WO). In South Africa, Cepton teamed up with partners to enable smart transportation infrastructure in Cape Town by developing vehicle detection solutions deployed across the city (https://ibn.fm/HZAWv).

Vehicle and road safety is at the forefront of modern automotive design, and here, Cepton seeks to take it up a notch again. Instead of just giving drivers an accurate picture of the surrounding environment, Cepton aims to push the current limits to provide an extended field of view for drivers and communicate additional information about road conditions and unseen hazards in real time. Joining forces with its partners committed to building the future of transportation, the company co-developed a system that – true to its name, Periscope – was able to “look around the corner” and warn the driver about five seconds before a pedestrian became visible, providing more time for drivers to react to potentially hazardous situations (https://ibn.fm/ocu4n).

Cepton has also been busy forging partnerships with other leading players across multiple regions – from North America to Europe, Africa and more. For example, Ford has been partnering with Cepton practically since the company’s inception in 2016, both for R&D collaboration and small-scale deployments, where Cepton’s lidars were used in some of Ford’s smart city projects (https://ibn.fm/DBLKE). In the UK, Cepton was part of an innovative project that aimed to help build safer, greener and smarter cities by transforming buses into mobile road inspection tools by equipping them with the tech to create a detailed map of the urban environment (https://ibn.fm/yS80w). Cepton’s most recent partnership lies within America’s tolling infrastructure, as the company scored a contract with one of the largest U.S. tolling system operators. Using Cepton’s Sora lidars, systems are beginning to roll out with high 3D imagery for all vehicles at top speeds in order to provide profiling for traffic congestion and toll leakage (https://ibn.fm/Oxmdd).

The current and future growth in lidar remains exciting, as this technology has the potential to disrupt many traditional industries, leading to higher productivity, safety, and convenience for all end consumers. As lidar deployment continues to advance rapidly, innovators like Cepton will keep forging onwards with new, disruptive applications.

For more information, visit the company’s website at www.Cepton.com.

NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all